Lucid Motors sets third straight quarterly sales record ahead of Gravity SUV launch

Date:

Share post:


Lucid Motors has now officially sold more EVs this year than it did in all of last year, and with three months to go in 2024.

The milestone comes after Lucid announced Monday it delivered 2,781 vehicles in the third quarter of 2024. That’s a third straight record quarter for deliveries, though Lucid is still well below the sales figures it once promised as part of the massive $4 billion reverse merger that made it a public company in 2021.

The upward trend in sales is happening at a crucial moment for Lucid, which keeps leaning on its majority owner — Saudi Arabia’s sovereign wealth fund — to inject more cash ahead of the launch of the electric automaker’s Gravity SUV later this year. That will be the company’s second model and, perhaps more importantly, comes in a far more popular form factor in its home market of North America.

Lucid did not break down where it’s been generating these increased sales. It may offer more insight when it reports its financial results for the quarter on November 7th. But the company has been stepping up shipments to Saudi Arabia in recent quarters, where it has a facility that performs final assembly of cars that were mostly-built at its main factory in Arizona. (Lucid plans to open a full-featured factory in Saudi Arabia in the coming years.)

While sales were up, the company said Monday that it only built 1,805 Air sedans in Q3, down from the 2,110 it produced in the second quarter. That means it will have to build more than 3,000 EVs in the fourth quarter if it wants to hit its stated goal of making 9,000 vehicles this year — something it’s only ever done once, back in the fourth quarter of 2022.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

OpenAI’s GPT-5 reportedly falling short of expectations

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t...

OpenAI announces new o3 model — but you can’t use it yet

Welcome back to Week in Review. This week, we’re looking at OpenAI’s last — and biggest —...

Google pushes back against DOJ’s ‘interventionist’ remedies in antitrust case

Google has offered up its own proposal in a recent antitrust case that saw the US Department...

If climate tech is dead, what comes next?

Humans have an innate desire to name things, but to be honest, we’re not always that good...

Hollywood angels: Here are the celebrities who are also star VCs

Becoming a venture capitalist has become the latest status symbol in Hollywood.  Everyone these days, from Olivia Wilde...

Meet Skyseed, a VC fund and incubator backing the Bluesky and AT Protocol ecosystem

On November 15, Peter Wang posted a message requesting ideas for a new incubator and fund to...

Sam Altman disputes Marc Andreessen’s description of AI meetings with Biden administration

Famed investor Marc Andreessen recently talked about meetings with Biden administration staff who gave him the impression...

EV startup Canoo places remaining employees on a ‘mandatory unpaid break’

Struggling electric van startup Canoo has placed its remaining employees on what it’s calling a “mandatory unpaid...